|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takenaka Y, Yasui T, Enomoto K, Miyabe H,
Morizane N, Ashida N, Shimizu K, Hirose M, Yamamoto Y and Uno A:
Health insurance status and survival among patients with head and
neck cancer in Japan. Int J Clin Oncol. 21:517–522. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Razzouk S: Translational genomics and head
and neck cancer: Toward precision medicine. Clin Genet. 86:412–421.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Machiels JP, Lambrecht M, Hanin FX, Duprez
T, Gregoire V, Schmitz S and Hamoir M: Advances in the management
of squamous cell carcinoma of the head and neck. F1000Prime Rep.
6:442014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sanderson RJ and Ironside JA: Squamous
cell carcinomas of the head and neck. BMJ. 325:822–827. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Merino OR, Lindberg RD and Fletcher GH: An
analysis of distant metastases from squamous cell carcinoma of the
upper respiratory and digestive tracts. Cancer. 40:145–151. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grégoire V, Lefebvre JL, Licitra L and
Felip E: EHNS- ESMO-ESTRO Guidelines Working Group: Squamous cell
carcinoma of the head and neck: EHNS-ESMO-ESTRO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol.
21(Suppl 5): v184–v186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schweitzer A, Knauer SK and Stauber RH:
Nuclear receptors in head and neck cancer: Current knowledge and
perspectives. Int J Cancer. 126:801–809. 2010.PubMed/NCBI
|
|
9
|
Wu CT, Chang YL, Shih JY and Lee YC: The
significance of estrogen receptor beta in 301 surgically treated
non-small cell lung cancers. J Thorac Cardiovasc Surg. 130:979–986.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kawai H, Ishii A, Washiya K, Konno T, Kon
H, Yamaya C, Ono I, Minamiya Y and Ogawa J: Estrogen receptor alpha
and beta are prognostic factors in non-small cell lung cancer. Clin
Cancer Res. 11:5084–5089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng J, Lee EJ, Madison LD and Lazennec
G: Expression of estrogen receptor beta in prostate carcinoma cells
inhibits invasion and proliferation and triggers apoptosis. FEBS
Lett. 566:169–172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reese JM, Suman VJ, Subramaniam M, Wu X,
Negron V, Gingery A, Pitel KS, Shah SS, Cunliffe HE, McCullough AE,
et al: ERβ1: Characterization, prognosis, and evaluation of
treatment strategies in ERα-positive and -negative breast cancer.
BMC Cancer. 14:7492014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jassam N, Bell SM, Speirs V and Quirke P:
Loss of expression of oestrogen receptor beta in colon cancer and
its association with Dukes' staging. Oncol Rep. 14:17–21.
2005.PubMed/NCBI
|
|
14
|
Lukits J, Remenár E, Rásó E, Ladányi A,
Kásler M and Tímár J: Molecular identification, expression and
prognostic role of estrogen-and progesterone receptors in head and
neck cancer. Int J Oncol. 30:155–60. 2007.PubMed/NCBI
|
|
15
|
Ferlay J, Autier P, Boniol M, Heanue M,
Colombet M and Boyle P: Estimates of the cancer incidence and
mortality in Europe in 2006. Ann Oncol. 18:581–592. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Budai B, Remenár E, Orosz Z, Számel I,
Kralovánszky J and Kásler M: Steroid hormone receptors in squamous
cell carcinoma of the head and neck. Orv Hetil. 138:723–727.
1997.(In Hungarian). PubMed/NCBI
|
|
17
|
Virolainen E, Tuohimaa P, Aitasalo K,
Kyttä J and Vanharanta- Hiltunen R: Steroid hormone receptors in
laryngeal carcinoma. Otolaryngol Head Neck Surg. 94:512–517. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oğretmenoğlu O and Ayas K: Laryngeal
carcinoma and estrogen receptor analysis in patients after
long-term follow-up. Eur Arch Otorhinolaryngol. 255:457–461. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goulioumis AK, Fuxe J, Varakis J, Repanti
M, Goumas P and Papadaki H: Estrogen receptor-beta expression in
human laryngeal carcinoma: Correlation with the expression of
epithelial-mesenchymal transition specific biomarkers. Oncol Rep.
22:1063–1068. 2009.PubMed/NCBI
|
|
20
|
Egloff AM, Rothstein ME, Seethala R,
Siegfried JM, Grandis JR and Stabile LP: Cross-talk between
estrogen receptor and epidermal growth factor receptor in head and
neck squamous cell carcinoma. Clin Cancer Res. 15:6529–6540. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th. Springer;
New York: pp. 29–35. 2010
|
|
22
|
Niu XL, Wang Y, Yao Z, Duan H, Li Z, Liu
W, Zhang H and Deng WM: Autocrine interferon-γ may affect malignant
behavior and sensitivity to tamoxifen of MCF-7 via estrogen
receptor β subtype. Oncol Rep. 34:3120–3130. 2015.PubMed/NCBI
|
|
23
|
Licitra L, Bernier J, Grandi C, Locati L,
Merlano M, Gatta G and Lefebvre JL: Cancer of the larynx. Crit Rev
Oncol Hematol. 47:65–80. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bianchini C, Pastore A, Pelucchi S,
Torreggiani E, Lambertini E, Marchesi E, Magri E, Frasson C,
Querzoli P and Piva R: Sex hormone receptor levels in laryngeal
carcinoma: A comparison between protein and RNA evaluations. Eur
Arch Otorhinolaryngol. 265:1089–1094. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hagedorn HG and Nerlich AG: Analysis of
sex-hormone-receptor expression in laryngeal carcinoma. Eur Arch
Otorhinolaryngol. 259:205–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schuller DE, Abou-Issa H and Parrish R:
Estrogen and progesterone receptors in head and neck cancer. Arch
Otolaryngol. 110:725–727. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferguson BJ, Hudson WR and McCarty KS Jr:
Sex steroid receptor distribution in the human larynx and laryngeal
carcinoma. Arch Otolaryngol Head Neck Surg. 113:1311–1315. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nozoe T, Oyama T, Takenoyama M, Hanagiri
T, Sugio K and Yasumoto K: Significance of immunohistochemical
expression of estrogen receptors alpha and beta in squamous cell
carcinoma of the esophagus. Clin Cancer Res. 13:4046–4050. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang QM, Qi YJ, Jiang Q, Ma YF and Wang
LD: Relevance of serum estradiol and estrogen receptor beta
expression from a high-incidence area for esophageal squamous cell
carcinoma in China. Med Oncol. 28:188–193. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dong J, Jiang SW, Niu Y, Chen L, Liu S, Ma
T, Chen X, Xu L, Su Z and Chen H: Expression of estrogen receptor α
and β in esophageal squamous cell carcinoma. Oncol Rep.
30:2771–2776. 2013.PubMed/NCBI
|
|
31
|
Ishida H, Wada K, Masuda T, Okura M,
Kohama K, Sano Y, Nakajima A, Kogo M and Kamisaki Y: Critical role
of estrogen receptor on anoikis and invasion of squamous cell
carcinoma. Cancer Sci. 98:636–643. 2007. View Article : Google Scholar : PubMed/NCBI
|
